Cardiotoxicity due to chemotherapy for breast cancer: The dark side of the moon
Open Access
- 22 January 2015
- journal article
- Published by AVES YAYINCILIK A.Ş. in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
- Vol. 15 (1) , 61-62
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancerAnadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2015
- A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced NephropathyBioMed Research International, 2014
- Cardio-Oncology: Role of EchocardiographyProgress in Cardiovascular Diseases, 2014
- Three-Dimensional Echocardiography and Cardiac Magnetic Resonance Imaging in the Screening of Long-Term Survivors of Childhood Cancer After Cardiotoxic TherapyThe American Journal of Cardiology, 2014
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline CardiotoxicityThe American Journal of Cardiology, 2013
- Temporal Changes in Standard and Tissue Doppler Imaging Echocardiographic Parameters After Anthracycline Chemotherapy in Women With Breast CancerThe American Journal of Cardiology, 2013
- Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: The LITE (Liposomal doxorubicin–Investigational chemotherapy–Tissue doppler imaging Evaluation) randomized pilot studyInternational Journal of Cardiology, 2013
- Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline ChemotherapyJACC, 2012
- Cardio‐Oncology/Onco‐CardiologyClinical Cardiology, 2010
- Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy.2007